stella
beta
Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients — Stella
Recruiting
Back to Transfusion-dependent Beta-Thalassemia trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin Municipality
View full record on ClinicalTrials.gov